Peripheral blood-derived CD34+ progenitor cells:: CXC chemokine receptor 4 and CC chemokine receptor 5 expression and infection by HIV

被引:0
作者
Ruiz, ME
Cicala, C
Arthos, J
Kinter, A
Catanzaro, AT
Adelsberger, J
Holmes, KL
Cohen, OJ
Fauci, AS
机构
[1] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Immunopathol Lab, NIH, Bethesda, MD 20892 USA
[3] NCI, Frederick Canc Res & Dev Ctr, Sci Applicat Int Corp, NIH, Frederick, MD 21702 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The present study demonstrates cell surface expression of both CXC chemokine receptor 4 (CXCR4) and CC chemokine receptor 5 (CCR5), major coreceptors for T cell-tropic and macrophage-tropic strains of HIV, respectively, on CD34(+) progenitor cells derived from the peripheral blood. CD34+ progenitor cells were susceptible to infection by diverse strains of HIV, and infection could be sustained for prolonged periods in vitro. HIV entry into CD34(+) progenitor cells could be modulated by soluble CD4, HIV gp120 third variable loop neutralizing mAb and the cognate ligands for the CXCR4 and CCR5 HIV coreceptors, This study suggests that a significant proportion of the circulating progenitor cell pool may serve as a reservoir for HIV that is capable of trafficking the virus to diverse anatomic compartments. Furthermore, the infection and ultimate destruction of these progenitor cells may explain in part the defective lymphopoiesis in certain HIV-infected individuals despite effective control of virus replication during highly active antiretroviral therapy.
引用
收藏
页码:4169 / 4176
页数:8
相关论文
共 70 条
[1]  
AIUTI A, 1997, J EXP MED, V185, P11
[2]   CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J].
Alkhatib, G ;
Combadiere, C ;
Broder, CC ;
Feng, Y ;
Kennedy, PE ;
Murphy, PM ;
Berger, EA .
SCIENCE, 1996, 272 (5270) :1955-1958
[3]   HIV coreceptor downregulation as antiviral principle: SDF-1 alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication [J].
Amara, A ;
LeGall, S ;
Schwartz, O ;
Salamero, J ;
Montes, M ;
Loetscher, P ;
Baggiolini, M ;
Virelizier, JL ;
ArenzanaSeisdedos, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :139-146
[4]   Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines [J].
Atchison, RE ;
Gosling, J ;
Monteclaro, FS ;
Franci, C ;
Digilio, L ;
Charo, IF ;
Goldsmith, MA .
SCIENCE, 1996, 274 (5294) :1924-1926
[5]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[6]  
BAGNARA GP, 1990, EXP HEMATOL, V18, P426
[7]   Human immunodeficiency virus (HIV)-resistant CD4(+) UT-7 megakaryocytic human cell line becomes highly HIV-1 and HIV-2 susceptible upon CXCR4 transfection: Induction of cell differentiation by HIV-1 infection [J].
Baiocchi, M ;
Olivetta, E ;
Chelucci, C ;
Santarcangelo, AC ;
Bona, R ;
dAloja, P ;
Testa, U ;
Komatsu, N ;
Verani, P ;
Federico, M .
BLOOD, 1997, 89 (08) :2670-2678
[8]   A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains [J].
Berson, JF ;
Long, D ;
Doranz, BJ ;
Rucker, J ;
Jirik, FR ;
Doms, RW .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6288-6295
[9]   The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry [J].
Bleul, CC ;
Farzan, M ;
Choe, H ;
Parolin, C ;
ClarkLewis, I ;
Sodroski, J ;
Springer, TA .
NATURE, 1996, 382 (6594) :829-833
[10]  
CEN D, 1993, BRIT J HAEMATOL, V85, P596, DOI 10.1111/j.1365-2141.1993.tb03353.x